Clinical Trial 53195

Chesterfield, MO 63005


A Phase 3, Open-Label Study of Once Daily LY3502970 Compared with Insulin Glargine in Adult Participants with Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular Risk


Age 18 and older

Have an increased risk of cardiac events

BMI of ≥25

Have Type 2 Diabetes

Qualified Participants May Receive:

Compensation for time and travel

Medication and procedures covered

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.